English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Sanofi Us
+
Community
Press release submission
| May 8, 2018
SANOFI US: Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients
+
Regulatory
Carol Ostrow
| Oct 7, 2017
Dupixent gains approval as atopic dermatitis treatment in Europe
+
Technology/Innovation
Nicholas Gueguen
| Jul 23, 2017
Study: Dupixent used with topical corticosteroids improves atopic dermatitis
+
Regulatory
Nicholas Gueguen
| Jul 1, 2017
FDA OKs Kevzara for moderate to severe rheumatoid arthritis
+
Technology/Innovation
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
+
Technology/Innovation
Robert Hadley
| Apr 15, 2017
Toujeo maker touts drug’s ability to lower blood sugar
Erianne Leatherman
| Apr 5, 2017
Sanofi Genzyme expands Multiple Myeloma Journey Partners program
+
Regulatory
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
